Preclinical: A new way to starve cancer - Fight Prostate Ca...

Fight Prostate Cancer

2,986 members1,364 posts

Preclinical: A new way to starve cancer

Maxone73 profile image
2 Replies

Nothing to do with diet, at least I do not think so, but two promising new targets to test.

Researchers at Indiana University School of Medicine have identified a new way to target prostate cancer by depriving tumors of amino acids. The team found that when nutrients are depleted, a protein called GCN2 signals cells to make more fuel for growth. While inhibiting GCN2 slowed tumor growth, it didn't kill the cancer, which activated a backup plan.

The protein p53, which is retained in most prostate cancers, signals to restrict cell division and gather nutrients. The researchers discovered that inhibiting both GCN2 and p53 effectively destroyed prostate cancer cells. This approach exploits metabolic vulnerabilities unique to prostate cancer. The study was published in Science Signaling.

In my opinion the concept here is that (at least in mice) P53 deficient tumors (quite common mutation in prostate cancer) can effectively be targeted by GCN2 inhibition.

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Broccoli24 profile image
Broccoli24

This seems very exciting... now how easy is it to inhibit GNC2 & P53 I wonder... and will it have side effects? Something like the could be a much less invasive treatment for us. Wishing them Godspeed!

Maxone73 profile image
Maxone73 in reply toBroccoli24

let's hope to ge as reactive as mice!

I don't know about their side effects, but inhibition of both p53 and GNC2 is what they did to test their theory.

Not what you're looking for?

You may also like...

Preclinical: starving cancer...with fat! (and CRISPR)

Because you know...starving cancer is not possible....or maybe it is? Researchers at UCSF have...
Maxone73 profile image

Preclinical: a metastasis freezing new compound

Preclinical (but working at least in vivo)...but very very damn positive! I really like when I can...
Maxone73 profile image

Preclinical: Will bacteria save us?? A new amazing tool!

Researchers at UMass Amherst have developed BacID, a bacteria-based cancer therapy that uses...
Maxone73 profile image

Glutamine blockade to starve tumors, Using bacteria in the microbiome to attack cancer, 2 articles on finding dormant cancer cells in bone

Greetings FPC Members, First, a glutamine uptake blocker, IMD-0354, in development to starve...
NPfisherman profile image

SGLT-2 Inhibitors to (partially) “Starve” Glucose Dependent Cancers

There has been many theories proposed about how to “starve cancer”. And many have gone down rabbit...